Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods

被引:10
作者
Kransdorf, Evan P. [1 ]
Loghmanpour, Natasha A. [2 ]
Kanwar, Manreet K. [3 ]
Temkit, M'hamed H. [4 ]
Stehlik, Josef [5 ]
机构
[1] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA
[2] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA
[3] Allegheny Gen Hosp, Cardiovasc Inst, Pittsburgh, PA 15212 USA
[4] Mayo Clin Arizona, Div Hlth Sci Res, Scottsdale, AZ USA
[5] Univ Utah, Sch Med, Div Cardiovasc Med, Salt Lake City, UT USA
关键词
cardiac allograft vasculopathy; graft rejection; graft survival; heart transplantation; immunosuppression; HEART-TRANSPLANT RECIPIENTS; CORONARY-ARTERY-DISEASE; 10-YEAR FOLLOW-UP; INTRAVASCULAR ULTRASOUND; MYCOPHENOLATE-MOFETIL; INTERNATIONAL SOCIETY; RANDOMIZED-TRIAL; RISK SCORE; MORTALITY; DONOR;
D O I
10.1111/ctr.12925
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundCardiac allograft vasculopathy (CAV) remains an important cause of graft failure after heart transplantation (HT). Although many risk factors for CAV have been identified, there are no clinical prediction models that enable clinicians to determine each recipient's risk of CAV. MethodsWe studied a cohort of 14328 heart transplant recipients whose data were reported to the International Society for Heart and Lung Transplantation Registry between 2000 and 2010. The cohort was divided into training (75%) and test (25%) sets. Multivariable modeling was performed in the test set using variables available at the time of heart transplant using three methods: (i) stepwise Cox proportional hazard, (ii)regularized Cox proportional hazard, and (iii) Bayesian network. ResultsCardiac allograft vasculopathy developed in 4259 recipients (29.7%) at a median time of 3.0years after HT. The regularized Cox proportional hazard model yielded the optimal performance and was also the most parsimonious. We deployed this model as an Internet-based risk calculator application. ConclusionsWe have developed a clinical prediction model for assessing a recipient's risk of CAV using variables available at the time of HT. Application of this model may allow clinicians to determine which recipients will benefit from interventions to reduce the risk of development and progression of CAV.
引用
收藏
页数:12
相关论文
共 43 条
[1]   The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis [J].
Adamo, Luigi ;
Tang, Yuanyuan ;
Nassif, Michael E. ;
Novak, Eric ;
Jones, Philip G. ;
LaRue, Shane ;
Spertus, John A. ;
Mann, Douglas L. .
JACC-HEART FAILURE, 2016, 4 (12) :950-958
[2]   Long-Term Mortality After Cardiac Allograft Vasculopathy Implications of Percutaneous Intervention [J].
Agarwal, Shikhar ;
Parashar, Akhil ;
Kapadia, Samir R. ;
Tuzcu, E. Murat ;
Modi, Dhruv ;
Starling, Randall C. ;
Oliveira, Guilherme H. .
JACC-HEART FAILURE, 2014, 2 (03) :281-288
[3]   Risk Prediction Models for Mortality in Ambulatory Patients With Heart Failure A Systematic Review [J].
Alba, Ana C. ;
Agoritsas, Thomas ;
Jankowski, Milosz ;
Courvoisier, Delphine ;
Walter, Stephen D. ;
Guyatt, Gordon H. ;
Ross, Heather J. .
CIRCULATION-HEART FAILURE, 2013, 6 (05) :881-889
[4]   Induction Therapy With Antithymocyte Globulin in Patients Undergoing Cardiac Transplantation Is Associated With Decreased Coronary Plaque Progression as Assessed by Intravascular Ultrasound [J].
Azarbal, Babak ;
Cheng, Richard ;
Vanichsarn, Christopher ;
Patel, Jignesh K. ;
Czer, Lawrence S. ;
Chang, David H. ;
Kittleson, Michelle M. ;
Kobashigawa, Jon A. .
CIRCULATION-HEART FAILURE, 2016, 9 (01)
[5]   What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models [J].
Babyak, MA .
PSYCHOSOMATIC MEDICINE, 2004, 66 (03) :411-421
[6]   Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks [J].
Blanche, Paul ;
Dartigues, Jean-Francois ;
Jacqmin-Gadda, Helene .
STATISTICS IN MEDICINE, 2013, 32 (30) :5381-5397
[7]   Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: Multivariate risk factor analysis and role of immunosuppression [J].
Caforio, ALP ;
Tona, F ;
Fortina, AB ;
Angelini, A ;
Piaserico, S ;
Gambino, A ;
Feltrin, G ;
Ramondo, A ;
Valente, M ;
Iliceto, S ;
Thiene, G ;
Gerosa, G .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :962-970
[8]   The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients [J].
Costanzo, Maria Rosa ;
Dipchand, Anne ;
Starling, Randall ;
Anderson, Allen ;
Chan, Michael ;
Desai, Shashank ;
Fedson, Savitri ;
Fisher, Patrick ;
Gonzales-Stawinski, Gonzalo ;
Martinelli, Luigi ;
McGiffin, David ;
Parisi, Francesco ;
Smith, Jon ;
Taylor, David ;
Meiser, Bruno ;
Webber, Steven ;
Baran, David ;
Carboni, Michael ;
Dengler, Thomas ;
Feldman, David ;
Frigerio, Maria ;
Kfoury, Abdallah ;
Kim, Daniel ;
Kobashigawa, Jon ;
Shullo, Michael ;
Stehlik, Josef ;
Teuteberg, Jeffrey ;
Uber, Patricia ;
Zuckermann, Andreas ;
Hunt, Sharon ;
Burch, Michael ;
Bhat, Geetha ;
Canter, Charles ;
Chinnock, Richard ;
Crespo-Leiro, Marisa ;
Delgado, Reynolds ;
Dobbels, Fabienne ;
Grady, Kathleen ;
Kao, W. ;
Lamour, Jaqueline ;
Parry, Gareth ;
Patel, Jignesh ;
Pini, Daniela ;
Pinney, Sean ;
Towbin, Jeffrey ;
Wolfel, Gene ;
Delgado, Diego ;
Eisen, Howard ;
Goldberg, Lee ;
Hosenpud, Jeff .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (08) :914-956
[9]   Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist Devices The HeartMate II Risk Score [J].
Cowger, Jennifer ;
Sundareswaran, Kartik ;
Rogers, Joseph G. ;
Park, Soon J. ;
Pagani, Francis D. ;
Bhat, Geetha ;
Jaski, Brian ;
Farrar, David J. ;
Slaughter, Mark S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (03) :313-321
[10]  
DRUZDZEL MJ, 1999, P 1999 ANN S AM MED, P1206